Quantcast

Latest Bleeding Stories

2014-04-02 08:33:56

ATLANTA, April 2, 2014 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has received approval of its Investigational Device Exemption (IDE) for PerClot from the United States Food and Drug Administration (FDA). This approval allows CryoLife to begin its pivotal clinical trial to gain approval to commercialize PerClot in the U.S. The Company plans to begin enrollment in...

2014-03-24 08:28:01

The Approval of ALPROLIX is First Significant Advance in Hemophilia B Treatment in More Than 17 Years CAMBRIDGE, MA, March 24, 2014 /CNW/ - Biogen Idec (NASDAQ: BIIB) has announced that Health Canada approved ALPROLIX((TM) )[Coagulation Factor IX (Recombinant), Fc Fusion Protein], for the control and prevention of bleeding episodes and routine prophylaxis in adults, and children aged 12 and older, with hemophilia B. ALPROLIX is the first approved long-acting hemophilia B therapy and...

2014-03-01 23:01:52

The Firm is investigating Pradaxa lawsuits on behalf of individuals who allegedly suffered serious episodes of internal bleeding, allegedly due to their use of the blood thinner. New York, New York (PRWEB) March 01, 2014 As Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/ ) continue to mount in federal court, Bernstein Liebhard LLP notes that a recent media investigation has found that the blood thinner ranks as the most complained about prescription medication in the U.S. According...

2014-02-28 23:31:34

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com Chicago, IL (PRWEB) February 28, 2014 The prescription drug safety advocates at DrugRisk.com are announcing updated legal news on the site for patients taking the blood thinner Pradaxa. Recent court records show the number of lawsuits alleging the drug caused internal bleeding have risen since January*. DrugRisk was created to give...

2014-02-25 14:19:07

New approach could help doctors and surgeons diagnose blood coagulation status in near real time, significantly improving patient care Defective blood coagulation is one of the leading causes of preventable death in patients who have suffered trauma or undergone surgery. The body’s natural defense against severe blood loss is the clotting process, in which platelets, plasma proteins, and other blood components interact to form a sticky, mesh-like structure. But often things go wrong, and...

2014-02-25 08:32:34

WESTPORT, Conn., Feb. 25, 2014 /PRNewswire/ -- TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, is pleased to announce that due to the rapid incremental sales growth on the HemCon hemostatic antibacterial woundcare line in the professional hospital market, the company has decided to accelerate the national expansion of their dental product line in North America. A reported ten...

2014-02-24 23:03:02

The attorneys at Bernstein Liebhard LLP are evaluating potential Pradaxa lawsuit claims from individuals who may have experienced serious episodes of internal bleeding caused by the anti-coagulant. New York, NY (PRWEB) February 24, 2014 Thousands of recently-filed Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) are alleging that certain researchers and medical institutions may have concealed vital safety data about the blood-thinner in clinical trials that led to its U.S. approval,...

2014-02-20 08:30:34

LONDON, Feb. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: EpiCast Report: Hemophilia - Epidemiology Forecast to 2022 EpiCast Report: Hemophilia - Epidemiology Forecast to 2022 Summary Hemophilia is an X-linked hereditary bleeding disorder characterized by impaired blood coagulation as a result of deficiencies in the production or function of coagulation factor VIII (hemophilia A) or factor IX (hemophilia B). Because of the deficiency of...

2014-02-18 04:21:07

- The PROTECT VIII study met its primary efficacy and safety objectives for the treatment of patients with hemophilia A WHIPPANY, N.J., Feb. 18, 2014 /PRNewswire/ -- Bayer HealthCare today announced positive results from the PROTECT VIII trial evaluating the company's investigational long-acting site-specific PEGylated recombinant human factor VIII compound BAY 94-9027. The study met its primary objective of protection from bleeds with fewer infusions. In the study, the...

2014-02-15 23:00:34

The Firm is evaluating Pradaxa lawsuits on behalf of individuals who suffered cerebral hemorrhage, gastrointestinal bleeding, and other serious bleeding events, allegedly due to Pradaxa. New York, New York (PRWEB) February 15, 2014 Boehringer Ingelheim has acknowledged being named a defendant in more than 2,000 Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) pending in U.S. courts that allege the company failed to warn patients about the potential for serious and uncontrollable...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related